Conditions: Dermatofibrosarcoma Protuberans
Keywords: newly diagnosed or recurrent
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 18
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the effect of imatinib on dermatofibrosarcoma protuberan tumors.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: imatinib mesylate
Intervention descriptions: intervention 1: 400 mg orally twice a day for 10 - 14 days

Protocol document: